Differential diagnosis of thrombotic microangiopathy in nephrology

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F17%3A00076150" target="_blank" >RIV/00023001:_____/17:00076150 - isvavai.cz</a>

Výsledek na webu

<a href="https://bmcnephrol.biomedcentral.com/track/pdf/10.1186/s12882-017-0727-y?site=bmcnephrol.biomedcentral.com" target="_blank" >https://bmcnephrol.biomedcentral.com/track/pdf/10.1186/s12882-017-0727-y?site=bmcnephrol.biomedcentral.com</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1186/s12882-017-0727-y" target="_blank" >10.1186/s12882-017-0727-y</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Differential diagnosis of thrombotic microangiopathy in nephrology

Popis výsledku v původním jazyce

Background: The differential diagnosis of thrombotic microangiopathy (TMA) is complex however the rapid diagnosis of the underlying condition is vital to inform urgent treatment decisions. A survey was devised with the objective of understanding current practices across Europe and the Middle East, and of challenges when diagnosing the cause of TMA. Methods: Over 450 clinicians, from 16 countries were invited to complete an online survey. Conclusions: This survey reveals the variability of current practices and the need for increased urgency among physicians in the differential diagnosis of TMA, despite their experience. Above all, the survey highlights the need for international clinical guidelines to provide systematically developed recommendations for understanding the relevance of complement protein levels, complement abnormalities and ADAMTS13 testing, in making a differential diagnosis of TMA. Such clinical guidelines would enable physicians to make a more rapid and informed diagnosis of TMA, therefore initiate effective treatment earlier, with a consequent improvement in patient outcomes.

Název v anglickém jazyce

Differential diagnosis of thrombotic microangiopathy in nephrology

Popis výsledku anglicky

Background: The differential diagnosis of thrombotic microangiopathy (TMA) is complex however the rapid diagnosis of the underlying condition is vital to inform urgent treatment decisions. A survey was devised with the objective of understanding current practices across Europe and the Middle East, and of challenges when diagnosing the cause of TMA. Methods: Over 450 clinicians, from 16 countries were invited to complete an online survey. Conclusions: This survey reveals the variability of current practices and the need for increased urgency among physicians in the differential diagnosis of TMA, despite their experience. Above all, the survey highlights the need for international clinical guidelines to provide systematically developed recommendations for understanding the relevance of complement protein levels, complement abnormalities and ADAMTS13 testing, in making a differential diagnosis of TMA. Such clinical guidelines would enable physicians to make a more rapid and informed diagnosis of TMA, therefore initiate effective treatment earlier, with a consequent improvement in patient outcomes.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30218 - General and internal medicine

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

BMC nephrology [online]

ISSN

1471-2369

e-ISSN

—

Svazek periodika

18

Číslo periodika v rámci svazku

October 28

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

8

Strana od-do

"art. no. 324"

Kód UT WoS článku

000413978400001

EID výsledku v databázi Scopus

—